KINGSEMI: A Scarce Domestic Track Asset, Priced Well Ahead of the Evidence

The company’s early path also explains why its later move into front-end track took time. The current annual-report summary says Kingsemi’s products now cover front-end coat/develop, front-end cleaning, advanced-packaging wet tools, and smaller-wafer compound-semiconductor equipment. That is a broad map, but it was not built all at once. The product sequence suggests a deliberate climb: start where process complexity, customer validation burden, and foreign-lockout are manageable; learn integration and motion-control discipline; then push toward the harder front-end problem where validation takes longer but strategic value is much higher. That arc is typical of successful domestic semicap challengers in China. What is unusual is that Kingsemi chose one of the most concentrated and technically sticky tool categories in the entire front-end flow.

2.2 Birth node and listing path

Kingsemi listed on the STAR Market on 2019-12-16. The Shanghai Stock Exchange company page confirms the listing date; market data sources and the listing announcement materials show an IPO price of CNY 26.97 per share and an issue size of 21 million shares. The prospectus describes the company at the time as a semiconductor-special-equipment maker focused on coat/develop and single-wafer wet tools. That was the core IPO story: a domestic equipment company positioned in process steps where China still depended heavily on imports, with enough existing customer validation to be more than a concept stock, but still small enough for the market to price large optionality into future localization gains.

The capital-markets pitch at listing was not “we are already the Chinese TEL.” It was closer to “we are one of the few domestic vendors with a credible path into a bottleneck front-end step.” That distinction matters, because the company’s present valuation sometimes reads as though the first claim has already become true. It has not. The more defensible version is that the IPO marked the beginning of a period in which China’s market became willing to fund hard-tech equipment names before full margin maturity, as long as they could point to real installed tools, rising domestic fab demand, and expanding process reach. Kingsemi fit that window almost perfectly.

2.3 Stage division

The first stage ran from founding through roughly the mid-2010s. This was the capability-building stage. The company had to become a real equipment maker before it could become a strategic national-substitution candidate. The economic logic was practical: attack niches where domestic customers would accept a locally adapted tool if it solved throughput, yield, or service problems without demanding immediate parity with the best imported front-end platforms. This period left the company with the engineering base to move beyond smaller-wafer and packaging-oriented applications. The lasting impact was not financial scale. It was organizational muscle.

The second stage ran into the 2019 listing and centered on entering front-end track with enough maturity to persuade public investors that this was a real industrial candidate, not just an R&D claim. In prospectus materials and later filings, the company consistently framed coat/develop as a complex, high-barrier, strongly sticky step because of its tight coupling with lithography tools, materials, and customer process recipes. That meant the company had chosen a long game. Progress would be slow, but each successful validation would matter more than in lower-stakes equipment categories.

The third stage, from 2020 through 2023, was the domestic-substitution acceleration phase. China’s fab spending and policy urgency gave semicap names a stronger demand backdrop, and Kingsemi’s financials improved meaningfully by 2023: revenue reached CNY 1.717 billion and attributable net profit CNY 250.6 million. But the same year also exposed the working-capital characteristics of the model. Operating cash flow in 2023 was negative CNY 562.9 million even though net profit was positive, largely because inventory and receivables rose sharply while operating payables moved the other way. The business was growing, but the growth was balance-sheet hungry. That was an early warning that future revenue growth would not always feel like current cash creation.

The fourth stage began in 2024 and is still underway. This is the platform-transition and control-change phase. In 2024 the company publicly launched its front-end chemical cleaning machine. By the 2025 annual-report summary, it was claiming more than 90% process coverage for multiple SPM applications, successful customer process validation, and repeat orders from several large domestic customers. At the same time, profitability weakened sharply in 2025 as hiring, R&D, subsidy normalization, and inventory impairment hit the income statement. Then the ownership structure changed decisively. NAURA moved in during 2025, became controlling shareholder in June, replaced the prior no-controller structure with a state-backed platform structure, and began consolidating the business. That leaves Kingsemi in a different strategic category from the one in which it listed. It is now both an operating company and a portfolio piece inside a larger domestic semicap platform.

2.4 Key-node deep dive

The 2019 listing was important, but not because the IPO itself changed the business overnight. In hindsight, it was underrated as a financing event and overrated as a proof point. What it genuinely changed was the company’s access to growth capital and public-market visibility at the exact moment the STAR Market was becoming the preferred venue for China hard-tech stories. That capital access helped the company fund the long validation cycle of front-end tools without immediately sacrificing the chance to expand into adjacent products.

The 2024 launch and 2025 commercialization progress of the front-end chemical cleaner look more consequential. This is the first sign that Kingsemi may not remain permanently dependent on one flagship process segment. The annual-report summary says the cleaner’s process coverage exceeds 90%, that cleanliness already meets advanced-node requirements, that three core indicators can benchmark against overseas leaders, and that repeat orders have already been won from multiple large domestic customers. If those claims continue to translate into delivered revenue, Kingsemi stops being a one-wager company and starts becoming a broader wet-process platform. That would genuinely alter the earnings power of the franchise.

The March-to-June 2025 NAURA transaction genuinely changed the company’s fate. The structure was unusually clear. First, NAURA signed to acquire 9.49% from Advanced Manufacturing at CNY 88.48 per share for about CNY 1.687 billion. Second, it pursued the 8.41% block from Zhongke Tiansheng through a public transfer process with a minimum price of CNY 85.71 per share. Once those transfers completed, NAURA held 17.87%, secured four non-independent and one independent board seat, and Kingsemi declared that control had changed to NAURA, with Beijing Electronics Holdings as ultimate controller. In corporate-governance terms, that is a much bigger event than the percentage alone suggests. Control here came from both ownership and board composition.

What still matters today is not whether the control change happened. It did. What matters is what kind of parent NAURA is. It is not a financial buyer. Its own product map includes etch, deposition, furnace, cleaning, rapid thermal processing, and crystal growth, and it described Kingsemi’s portfolio as complementary in coat/develop and related wet tools. NAURA’s 2025 annual report then consolidated Kingsemi and recorded more than CNY 2.1 billion of goodwill from the purchase. That means the industrial logic is already formalized inside the balance sheet. If procurement leverage, customer access, or joint process-integration wins do not emerge over the next several reporting cycles, the strategic narrative will weaken much faster than the original acquisition headlines did.

3. Financial vertical review

2.5 Financial vertical review

The numbers tell a story of real commercial progress, but not yet of a stable compounding machine. The three-year data in the 2025 annual-report summary show revenue moving from CNY 1.717 billion in 2023 to CNY 1.754 billion in 2024 and CNY 1.948 billion in 2025. The top line did not collapse. What changed was the cost and cash profile of achieving it. Attributable net profit went from CNY 250.6 million in 2023 to CNY 202.8 million in 2024 and CNY 71.7 million in 2025; deducting non-recurring items, 2025 turned negative. Return on equity fell from 11.24% in 2023 to 8.10% in 2024 and 2.62% in 2025. That is not what demand destruction looks like. It is what an investment-heavy, price-sensitive scaling phase looks like when expenses rise faster than gross profit.

Revenue growth over this period came from product expansion, not from an easy pricing environment. The company’s disclosures show that it broadened from front-end track into front-end cleaning and advanced-packaging tools, and it continued to point to customer validation and repeat orders in new products. But the 2025 annual-report text also disclosed something less comfortable: some products faced price pressure while the company opened the market, enough to trigger higher inventory impairment because net realizable value fell below carrying value. That one line matters because it means the company is gaining ground in a market where customers still have bargaining power and where market entry is costly.

Cash-flow quality has been volatile enough to demand caution. In 2022, operating cash flow of about CNY 193.0 million was close to net profit of CNY 200.2 million. In 2023, operating cash flow fell to negative CNY 562.9 million while attributable net profit remained positive at CNY 250.6 million, mainly because inventories and operating receivables expanded sharply. In 2024, operating cash flow swung back to positive CNY 441.8 million. In 2025, it was still positive at CNY 103.0 million, but down 76.69% year on year. Then 2026 Q1 went back to negative CNY 343.5 million as procurement payments and payroll rose. This is not accounting manipulation by itself. It is the signature of an order-driven equipment business where cash collection, customer acceptance, pre-delivery production, and supplier terms can make one year look abundant and the next look starved. But it does mean investors should not treat accounting earnings as easily distributable owner earnings.

The balance sheet remains usable, but it is not as comfortable as the strategic narrative can make it sound. Total assets rose to CNY 6.44 billion by end-2025 from CNY 5.60 billion a year earlier. Equity rose only 3.77% to CNY 2.79 billion, much slower than asset growth, which tells you that working assets and liabilities were both expanding as the business scaled. That is normal for semicap, but it reduces the room for execution mistakes. When a company keeps adding people, inventory, and pre-delivery manufacturing effort while also broadening into new products, balance-sheet stress can appear before revenue fully catches up.

The company’s own R&D line supports the “investment phase” argument, but it does not fully absolve the margin story. R&D intensity was 16.92% of revenue in 2024 and 13.06% in 2025. On the face of it, 2025 R&D intensity fell, not rose, because revenue grew faster than R&D. The strong version of management’s argument is therefore slightly overstated if framed as “2025 profit fell mainly because R&D exploded.” The more precise reading is that Kingsemi has sustained a structurally high R&D burden for years while adding people and opening new markets, and 2025 exposed that the commercial gross-profit pool is not yet wide enough to absorb all of that investment smoothly. That is a different diagnosis from saying the business simply spends too much. It says the timing mismatch between capability build-out and monetization is still large.

4. Price and valuation history

2.6 Price and valuation history

Kingsemi’s price history has moved through four separate regimes. The first was the IPO and early STAR-board discovery phase, anchored on the CNY 26.97 issue price in December 2019. The second was the domestic-substitution rerating phase as semicap names became one of the market’s preferred ways to express policy support, fab expansion, and local-content substitution. The third mixed execution and volatility: growing revenue and credible product progress, but also a working-capital-heavy balance sheet and earnings that were more cyclical and lumpy than the narrative often suggested. The fourth, which culminated in June 2026, has been a pure valuation event.

The current phase has separated price from near-term earnings almost completely. The company’s own June 30, 2026 risk reminder disclosed that the stock had gained 78.98% within the month and that its dynamic P/E was significantly above the sector level. At the same time, trailing earnings still reflected a 64.64% fall in 2025 profit and a 24.70% decline in 2026 Q1 attributable profit. When a stock behaves like that, the market is not discounting the last four quarters. It is discounting a much larger future: successful front-end track localization, a real second growth leg in cleaning, and a faster commercialization curve under NAURA’s control.

Historically, that matters because the center of valuation has shifted from “specialized domestic semicap grower” to “scarce strategic asset.” Scarce strategic assets can deserve premium multiples. They do not deserve any premium at all. The question is whether the premium reflects something already operating in the business. At CNY 439.05, with market cap at CNY 88.52 billion and 2025 revenue at CNY 1.95 billion, Kingsemi trades around 45 times trailing sales. That puts it not just above traditional equipment norms, but above already-expensive Chinese semicap platforms. In practice, the historical question is no longer “is this below last year’s multiple?” The better question is “how much future success has already been pre-paid?” The answer is: an enormous amount.

5. Business model and moat

3.1 Revenue structure

Kingsemi still runs a simple revenue engine underneath a complicated technology story. The annual-report summary says the company makes money by selling semiconductor-special-equipment systems and related spares, with service income only a small supporting line. A third-party reading of the 2025 report’s product mix shows equipment revenue at 96.42% of total revenue, product spares at 2.44%, and other revenue at 1.14%. This is not a software-like model with recurring high-margin subscriptions. It is a sell-install-validate-support equipment model, so revenue depends on order intake, production scheduling, customer acceptance, and installation progress.

Inside that revenue engine, the economic center remains front-end coat/develop. The company’s own disclosures repeatedly call this the benchmark product line and emphasize just how technically sticky it is. What has changed is that management is no longer content to be judged only on that one category. The 2025 summary spends unusual time on front-end chemical cleaning and on advanced-packaging tools such as temporary bonding, debonding, and frame cleaning. That wording is not decoration. It reflects a company trying to widen its revenue base, increase content per fab, and reduce dependence on a single strategic bottleneck product.

3.2 Cost structure and operating leverage

The cost structure is exactly what you would expect from a serious semicap vendor trying to grow faster than the installed base can yet fund. R&D is structurally high. The company says it relies on internal development, combining foundational technology work, key subcomponent research, and whole-machine development. Production is mainly order-driven, with some pre-build for customers with tight lead times. Sales are mostly direct and include installation, process support, warranty, and training. All of that creates a business with meaningful fixed engineering and personnel cost, plus a working-capital burden that rises before revenue is recognized.

The 2025 earnings outcome shows that operating leverage currently works in the wrong direction when gross profit does not expand fast enough. Revenue rose, but net profit dropped sharply. The accessible annual-report text gives three main reasons: headcount-related salary and welfare expenses rose with business expansion, government subsidies booked through other income fell, and inventory impairment increased as some products faced price pressure. That is a classic semicap investment-phase squeeze. The fixed cost base is rising in anticipation of future scale, but the immediate gross-profit pool is not yet wide enough to absorb it. Short-term operating leverage is therefore negative.

3.3 Moat

The first real moat is switching cost tied to process validation. Kingsemi’s own industry discussion is unusually direct here. Front-end coat/develop tools are tightly coupled with customer manufacturing process, photoresist material, and lithography-tool integration; verification cycles are long and expensive; and once a tool is validated in-line with a customer’s process, stickiness becomes very strong. That is not a marketing moat. It is a real one. A validated track tool is deeply embedded in yield, throughput, defectivity, and line balance. Customers do not casually swap it unless a supplier fails badly or a new tool offers a compelling process edge.

The second moat is domestic scarcity in a category still dominated by imports. Kingsemi says the global front-end coat/develop market remains heavily monopolized by overseas vendors and that domestic localization is still low. Tokyo Electron’s own April 2026 disclosure is even blunter: it said its global coater/developer share exceeds 90%. In that context, Kingsemi does not need to displace the global leader everywhere to become economically important. It only needs to become the domestic default alternative in enough Chinese capacity additions and technology layers. That is why even partial success in front-end track can be strategically valuable.

The third moat is process adjacency. The front-end chemical cleaner is not just another product slot. If it succeeds, it gives Kingsemi another reason to sit inside the same manufacturing flow and another way to turn process knowledge into revenue. The company claims its cleaner covers more than 90% of relevant processes, has reached advanced-process cleanliness standards, has passed customer verification, and has begun winning repeat orders. That does not yet make Kingsemi a true cleaning leader. It does make the moat broader than it was two years ago.

What is not yet a proven moat is scale economics. Kingsemi does not have Tokyo Electron’s installed base, SCREEN’s cleaning breadth, NAURA’s platform scope, or AMEC’s R&D mass in etch. The company still has to spend hard to defend and extend its position, and 2025 showed that margins can compress when it pushes for market entry. So the moat is real but narrow. It is strongest in validated domestic front-end track deployments, emerging in cleaning, and still weak as a broad equipment-platform story.

3.4 Management and governance

Governance has changed more in the last year than in the prior five. Before June 2025, Kingsemi had no controlling shareholder or actual controller. After the two-step NAURA transaction and board change, Kingsemi explicitly disclosed that it now had a controlling shareholder, NAURA, and ultimate control by Beijing Electronics Holdings. NAURA nominees secured four non-independent and one independent board seat, giving the parent effective control of board composition. Whatever judgment one makes about the transaction, governance risk cannot be analyzed on the old stand-alone basis anymore.

That matters for management assessment. Historically, the company deserves credit for moving from a modest-origin equipment maker into a credible domestic front-end track supplier. The present governance chapter, however, is no longer only about the founding technical team. The current public-facing leadership already reflects the new order: investor communication in June 2026 was conducted under chairman Dong Boyu, while Kingsemi also disclosed the addition of several new core technical personnel with NAURA-linked backgrounds, including Deng Xiaojun, who had previously held product leadership roles inside North Huachuang’s equipment unit and then became Kingsemi director and executive committee chairman in June 2025. This looks less like financial engineering and more like direct industrial integration.

The positive read is stronger resource access, better procurement leverage, and broader customer reach. The negative read is that integration pressure can tempt a parent to optimize platform logic over stand-alone minority-shareholder logic. Kingsemi says the control change will not harm independence and will not adversely affect daily operations. That language is standard, and it deserves neither dismissal nor blind faith. The right approach is to watch related-party disclosures, board turnover, R&D personnel retention, and whether product-roadmap decisions continue to look commercially rational for Kingsemi itself rather than merely strategically convenient for NAURA’s broader platform.

6. Industry and cycle

4.1 Industry structure

Semiconductor equipment is a cyclical global industry, but the profit pool is not evenly spread. The global market remains dominated by a handful of foreign names in the highest-value front-end categories, while domestic challengers in China fight for share in areas where localization policy and customer need meet technical possibility. Industry data from SEMI show worldwide semiconductor equipment sales reached US$135.1 billion in 2025, up 15% year on year, with China still the largest regional market at US$49.3 billion. Kingsemi’s own industry section acknowledges the same structure in different language: high globalization, strong cyclicality, and a market where ASML, Applied Materials, Lam, Tokyo Electron, and KLA still control most global share.

Within that broad market, coat/develop is one of the tighter oligopolies. Tokyo Electron said in April 2026 that its coater/developer share exceeded 90% globally. That is why Kingsemi’s niche matters. It is entering a profit pool guarded not just by technology but by defectivity standards, throughput economics, and lithography-line integration. Cleaning is different. It is still high barrier, but the competitive field is wider and the process count is larger. Kingsemi’s own 2025 materials argue that cleaning steps account for more than 30% of all manufacturing steps and increase in both importance and count as nodes shrink and three-dimensional structures such as FinFET and GAA spread. A company with a credible cleaner alongside track can therefore enlarge its addressable market without abandoning its original process-intimacy advantage.

4.2 Cycle attributes

Kingsemi belongs to three cycles at once. The first is the semiconductor capex cycle. When logic, memory, or packaging investment rises, equipment demand improves with a lag and then arrives in batches through acceptance milestones. The second is the technology-iteration cycle. EUV adoption, multi-patterning requirements, advanced packaging, and finer geometries all change tool demand qualitatively; they are not just volume stories. The third is the policy cycle in China. Local-content urgency, export-control pressure, and procurement preference can all bring domestic tools into consideration earlier than pure global-market economics would imply.

Right now, the industry backdrop is supportive, but Kingsemi’s earnings still show that support does not automatically translate into smooth profitability. SEMI reported global equipment billings up 14% year on year in Q1 2026. TEL’s own outlook for fiscal 2027 highlighted particularly strong demand in coat/develop tied to EUV adoption by DRAM customers and EUV multi-patterning at logic customers. Those facts support the bullish case that the industry cycle is in an up-leg. But Kingsemi’s 2025 and Q1 2026 profitability show a company still spending ahead of smooth scale. So the cycle helps revenue opportunity more than it protects margins.

4.3 Policy, regulation, and geopolitics

Policy and geopolitics are not side issues here. They are part of the demand story. Kingsemi’s annual-report summary explicitly frames key equipment autonomy as more important as the global semiconductor landscape and market environment continue to change. That is corporate shorthand for a world in which export controls and technology fragmentation increase willingness among Chinese fabs to validate local tools even before those tools have fully erased the foreign performance gap. For a company in a low-localization category, that can bring customers forward in the funnel.

But geopolitics cuts both ways. It raises the odds of domestic substitution, yet it can also complicate component sourcing, stretch validation at advanced nodes, and keep foreign leaders focused on defending their most profitable segments. Kingsemi’s own 2025 report notes that some information has been withheld as commercial secret under disclosure rules. That is understandable in a competitive equipment market, but it also means outside investors see only part of the real process-roadmap and customer-mix picture. In a geopolitically sensitive industry, incomplete disclosure is not a red flag by itself. It is still a valuation constraint.

7. Horizontal competitor analysis

5.1 Judge the competitive landscape first

This is clearly Scenario C: there are several relevant peers, but not all on the same axis. The direct product references are Tokyo Electron in front-end coat/develop, SCREEN and ACM Research in wet processing and cleaning, and Kingsemi’s new parent NAURA plus domestic semicap leader AMEC as the capital-market comparables that frame what investors think a Chinese process-equipment platform might become. The important mistake is to pretend they are all interchangeable. They are not. Customers buy them for different reasons. Investors compare them because each expresses a different answer to the same question: where does stable profit pool control sit in semiconductor process equipment?

5.2 Horizontal comparison dimensions

Tokyo Electron has become the industry’s quality bar in coat/develop. Its April 2026 transcript said global coater/developer share exceeded 90%. Customers choose TEL because it is already embedded at the highest-value global process layers, because it can pair throughput with defect control, and because process integration with leading-edge lithography is already proven at scale. In fiscal 2025 TEL revenue reached JPY 2,431.5 billion, and the market still valued it at roughly JPY 34.4 trillion in June 2026. That combination of size and premium valuation tells you something basic: the market pays up for a supplier that already owns the profit pool, not one that merely wants to enter it.

SCREEN occupies a different ecological role. It is a broader process and cleaning player rather than a coat/develop hegemon. Customers choose SCREEN in cleaning because reliability, recipe breadth, and installed-base trust matter at least as much as headline novelty. Its June 2026 market cap was roughly JPY 3.15 trillion, and public quote pages show a far lower sales multiple than TEL’s. That fits the archetype: a respected, profitable, process-critical supplier, but without the exceptional scarcity value that coat/develop dominance commands.

ACM Research is the most useful product-led wet-processing comparator for Kingsemi’s second leg. ACM’s 2025 revenue reached US$901 million, and US$626 million of that, or 69.5%, came from single-wafer cleaning, Tahoe and semi-critical cleaning equipment. Customers choose ACM primarily for wet-process productivity and a portfolio built around the commercial reality of Chinese fabs. That makes ACM a better lens for assessing Kingsemi’s cleaning ambition than TEL is. Where Kingsemi differs is that Kingsemi’s strategic scarcity sits first in front-end track and only second in cleaning, while ACM’s identity is the other way around.

NAURA is no longer just a peer; it is the owner platform. Customers choose NAURA because it offers a widening domestic front-end process stack across etch, deposition, furnace, cleaning, RTP, and more. In 2025 NAURA generated CNY 39.35 billion of revenue, and by June 2026 its market capitalization was about CNY 641.9 billion. The market prices it as the domestic platform champion, not a narrow product story. That is exactly why the takeover matters. It gives Kingsemi access to an ecosystem it could not have built alone. It also raises the standard by which investors will judge it. Once you belong to a platform leader, “interesting niche specialist” is no longer enough.

AMEC is the domestic technology comparison that sharpens the contrast. AMEC’s 2025 annual report shows CNY 12.38 billion of semiconductor-equipment-related product revenue, a 39.17% gross margin, and R&D spending of about CNY 3.74 billion, equal to 30.23% of revenue. Public quote pages put its market cap around CNY 439.0 billion by late June 2026. Customers buy AMEC because it has become a real leader in plasma etch and a serious force in adjacent deposition categories. Investors pay a premium because it combines domestic-substitution upside with far more scaled execution than Kingsemi currently has. Comparing the two makes the gap obvious: Kingsemi’s strategic category may be scarce, but its revenue base, margin resilience, and R&D mass are still much thinner.

5.3 Ecological-niche analysis

Kingsemi’s niche is that of a domestic challenger with one unusually strategic franchise and one emerging adjacent leg. In front-end track, it attacks a profit pool still heavily defended by Tokyo Electron. In front-end cleaning, it is trying to move from “promising new product” to “repeat-order vendor.” In the domestic ecosystem, that places it between two categories. It is too advanced to be a mere follower, yet not broad enough to be a true platform leader. It fills the gap that Chinese fabs and policymakers most want filled: a credible local track supplier that can gradually deepen process content around that position.

That niche becomes stronger if localization pressure increases, if advanced packaging remains capital-intensive, and if Kingsemi’s cleaning tools continue to win repeat orders. It becomes weaker if price competition intensifies before its installed base is large enough to defend margin, or if advanced-node validation stalls while the parent platform absorbs most of the customer mindshare. The profit pool Kingsemi is most directly trying to take still belongs first to Tokyo Electron in track and to foreign cleaning leaders in wet process. The pool most likely to take Kingsemi’s share, if it stumbles, is not NAURA or AMEC. It is the incumbent foreign vendor that never lost the account in the first place.

8. Current fundamentals and bull/bear divergence

6.1 Last 4 quarters

The last four reported quarters show why trailing P/E is almost useless here. 2025 quarterly revenue was CNY 275.3 million in Q1, CNY 433.8 million in Q2, CNY 281.1 million in Q3, and CNY 958.2 million in Q4. Attributable net profit was just CNY 4.7 million in Q1, CNY 11.3 million in Q2, negative CNY 26.0 million in Q3, and positive CNY 81.8 million in Q4. Operating cash flow followed the same lumpiness, swinging from negative CNY 198.6 million in Q1 and negative CNY 84.6 million in Q2 to positive CNY 50.9 million in Q3 and positive CNY 335.2 million in Q4. This is a business where delivery and acceptance timing can dominate the quarter.

2026 Q1 looked better on gross margin and worse on reported profit. Revenue rose 20.08% year on year to CNY 330.6 million. Attributable net profit fell 24.70% to CNY 3.5 million, but deducting non-recurring items, the loss narrowed sharply to negative CNY 7.6 million from negative CNY 40.1 million a year earlier. The company explained that revenue growth came from rising new orders and progress in deliveries and acceptance, while gross margin was 12.40 percentage points higher than a year earlier. At the same time, operating cash flow was negative CNY 343.5 million because procurement payments and payroll rose. This is a good example of what is really happening now: the income statement is no longer deteriorating across the board, but cash conversion remains rough and the business still needs working capital to support the ramp.

6.2 What is the market trading right now

The market is trading re-rating and platform logic more than near-term earnings. The company’s own June 30 risk alert said the stock’s June gain far outpaced major STAR-board indices and warned of overheated sentiment. That aligned almost perfectly with the narrative stack around the name: China semicap leadership under domestic substitution, the still-rare front-end track franchise, the early signs of cleaning commercialization, and the idea that NAURA can unlock cross-tool process integration, customer access, and procurement leverage. Those are powerful narratives. They are also mostly future narratives.

The real fundamentals underneath that narrative are more modest but not weak. Revenue is still growing. Gross margin recovered sharply in Q1 2026. New-product commercialization has become more credible, especially in chemical cleaning. The control change is completed, not speculative. The problem is that valuation has moved much faster than those fundamentals. When a stock with CNY 71.7 million of 2025 attributable profit reaches CNY 88.5 billion of market cap, the market is telling you it cares far more about 2028 than 2025. That can work only if execution remains unusually clean.

6.3 Bull/bear divergence

The bulls have four strong pieces of evidence. First, Kingsemi has a real foothold in a bottleneck category where China still lacks many local alternatives, and its higher-end front-end track tools have already achieved in-line mass-production work with mainstream lithography tools in complex processes. Second, the front-end chemical cleaner has advanced from launch to customer validation and repeat orders from multiple large domestic customers, which is exactly the kind of adjacent proof the market wants. Third, the Q1 2026 gross-margin rebound shows that part of the 2025 profit problem was timing and mix rather than permanent commercial damage. Fourth, the NAURA control change is closed and gives Kingsemi access to a larger domestic semicap platform rather than leaving it to fight as a stand-alone niche vendor.

The bears also have four strong pieces of evidence. First, 2025’s profit decline was not just R&D; the annual-report text also points to lower subsidies and higher inventory impairment because some products faced price pressure. Second, cash generation is unstable even in growth periods, with negative operating cash flow in 2023 and again in 2026 Q1. Third, foreign competition remains brutal in the core segment, with TEL still saying its global coater/developer share exceeds 90%. Fourth, the market has already priced several years of success into the stock after a one-month 78.98% move and a valuation that the company itself flagged as far above industry norms.

9. Valuation analysis

7.1 Historical valuation

Kingsemi’s current valuation is best described as an extreme rather than as a percentile. The stock closed at a record level on June 30, 2026, and the company immediately published a risk reminder saying dynamic P/E was far above the industry. With a market cap of CNY 88.52 billion against 2025 revenue of CNY 1.95 billion and TTM EPS of roughly CNY 0.35–0.36, the stock is at about 45 times trailing sales and roughly 1,250 times trailing earnings. That is not a normal cyclical-semicap multiple; it is a scarcity-and-optionality multiple.

7.2 Peer valuation

The peer picture makes the distortion clearer. NAURA’s June 30, 2026 market cap was about CNY 641.9 billion on 2025 revenue of CNY 39.35 billion, or roughly 16 times sales. AMEC’s market cap was about CNY 439.0 billion, and public quote pages put TTM P/E around 160.9 times; its 2025 report shows semiconductor-equipment-related product revenue of CNY 12.38 billion. ACM Research traded at about 8.4 times sales in the US market. TEL traded at about 14.0 times sales, SCREEN at about 5.2 times. Kingsemi at 45 times sales is therefore not merely “more expensive than peers.” It is priced as if its future category economics will eventually surpass those of much larger, more proven vendors.

7.3 Absolute valuation

7.3.0 Cash-flow passthrough

On cash conversion, the right answer is caution. Using comparable annual primary extracts, operating-cash-flow to net-income ran at about 0.96 times in 2022, negative 2.25 times in 2023, 2.18 times in 2024, and 1.44 times in 2025. The four-year average is distorted downward by the 2023 working-capital build, but that is precisely the point: accounting earnings do not pass through cleanly to cash in this model because inventory, receivables, customer acceptance, and supplier terms move violently with growth and delivery schedules.

The maintenance-capex split is not disclosed cleanly enough in accessible public extracts, so any owner-earnings estimate must be an approximation. A conservative way to think about it is to anchor maintenance capex around depreciation-and-upkeep needs rather than new-facility and capacity-expansion spending. With 2023 depreciation and amortization already above CNY 40 million and the business having expanded since then, a maintenance-capex proxy of roughly CNY 50–60 million a year is reasonable. On that basis, 2025 owner earnings are closer to CNY 40–50 million than to the headline CNY 71.7 million net profit, implying an owner-earnings multiple comfortably above the already absurd headline P/E. That is why the valuation below defaults to a revenue-and-margin scenario framework rather than trailing earnings.

7.3.1 Industry-fit method menu

For Kingsemi, the best fit is a blended semicap growth method: forward revenue scenarios, owner-earnings discipline, and terminal EV/Sales calibrated against how the market prices domestic semicap platforms and global process-equipment leaders. The key question is not whether Kingsemi deserves a premium to ordinary equipment makers. It does. The question is whether it deserves a premium to almost everyone already.

On those assumptions, I estimate today’s fair-value equivalents at roughly CNY 115 per share in the conservative case, CNY 195 in the base case, and CNY 320 in the optimistic case. This is valuation-scenario analysis within a research framework, not investment advice. The important point is not the precision of any one number. It is the gap between even a generous optimistic operating future and the current market price.

7.4 Expectation-gap analysis

The market is currently pricing a future in which Kingsemi becomes both the default domestic front-end track alternative and a meaningful front-end cleaner supplier, with NAURA accelerating that process enough to justify continued very high strategic multiples. The expectation gap is therefore not on revenue alone. It is on margin and scalability. Revenue can keep growing and the stock can still disappoint badly if price pressure, validation cost, or working-capital intensity keep owner earnings thin.

The metrics most likely to create that expectation gap are gross margin, repeat-order evidence in chemical cleaning, and rolling operating cash flow. The next earnings print matters less for absolute profit than for whether gross margin can stay above the mid-30s and whether cash conversion stops looking erratic. If bulls get stronger evidence of repeat orders and margin normalization, the narrative gains substance. If bears get another quarter of weak profit plus large cash burn, the mismatch between story and numbers will become too obvious to ignore.

7.5 Margin-of-safety recheck

At the current price, the margin of safety is zero. CNY 439.05 is not just above the conservative scenario. It is far above the optimistic scenario I can justify on operations.

The most fragile assumption in the base case is not revenue growth. It is the belief that margin can normalize meaningfully while the company is still forcing its way into imported-product profit pools. If you haircut the base-case margin assumption to 70% of what I have modeled, the base-case fair value falls from roughly CNY 195 to about CNY 150. That is what makes the current setup dangerous: the operating assumptions are not heroic on volume, but they are still quite sensitive on economics.

If earnings were flat for the next three years and the multiple merely normalized part of the way toward broader semicap peers, the annualized return from the current price would be poor and would trail the roughly 1.73% China 10-year government-bond yield by a wide margin in real investment merit, because the likely equity outcome would be negative rather than bond-like. At this buy price, there is no margin of safety. This is a good company and, at the current quote, a bad price. Waiting is not only justified. It is the rational default.

Margin-of-safety sufficiency verdict: none.

10. Risk analysis

8.1 Business risk

The biggest business risk is that localization wins come with structurally lower economics than the market expects. Probability is medium to high; impact is high. The 2025 annual-report text already says some products faced market-expansion price pressure severe enough to require extra inventory impairment. If that proves to be a feature rather than a one-year side effect, Kingsemi can keep winning orders while still failing to create the margin structure investors are paying for. The cleanest indicator is sustained gross margin below 35% or repeated impairment tied to market pricing. The transmission path is direct: lower margin hurts profit, weaker profit undermines the “future platform” narrative, and then the multiple compresses at the same time.

A second business risk is that the cleaning and bonding adjacencies take longer to scale than the current valuation assumes. Probability is medium; impact is high. The company has credible product progress here, but the commercial proof still rests on validation, repeat orders, and conversion into stable revenue. If the cleaner remains a promising new product rather than becoming a major order line, the whole “track plus clean platform” thesis shrinks back into a single-category story. The indicator is simple: watch for repeated disclosure of major-customer repeat orders and for revenue growth that is not entirely concentrated in lumpy track deliveries.

8.2 Financial risk

Working-capital strain is the most important financial risk. Probability is high; impact is medium to high. Kingsemi has now shown both sides of the cycle: healthy profits with ugly cash flow, then improved cash flow, then renewed cash burn in Q1 2026. This is typical equipment-business behavior, but the valuation leaves little room for a balance-sheet-heavy growth profile. The indicator is rolling four-quarter operating-cash-flow-to-net-income below 0.8 times, combined with inventories and receivables growing materially faster than revenue. The transmission path runs through financing flexibility and narrative durability. Investors tolerate working-capital drag when a stock is cheap. They punish it when the stock is priced for perfection.

8.3 Valuation risk

Valuation compression is the clearest risk and the one most likely to cause permanent capital loss from the current entry point. Probability is high; impact is very high. The company itself flagged overheated sentiment, a one-month share-price increase of 78.98%, and dynamic P/E far above the industry. On trailing sales, Kingsemi is already above larger, more proven domestic and global peers. When a stock is valued on future strategic scarcity rather than present earnings, disappointment does not need to be large. It only needs to be ordinary. The indicator is any quarter in which revenue remains decent but margin and cash flow fail to improve. The transmission path is multiple collapse first, earnings revision second.

8.4 Governance and external risk

The NAURA integration is both a strategic asset and a governance risk. Probability is medium; impact is medium to high. NAURA paid cash, secured control through ownership plus board seats, consolidated the company from June 30, 2025, and booked more than CNY 2.1 billion of goodwill. That creates pressure to show synergy. The benign version is that procurement, R&D, and customer resources improve. The less benign version is that Kingsemi’s stand-alone economics are asked to serve a broader platform agenda, while minority shareholders must trust that related-party behavior stays disciplined. The indicators are board turnover, related-party transaction intensity, core-technical-staff departures, and whether synergy language starts outpacing measurable operating improvement.

Foreign-competition risk remains permanent. Probability is medium; impact is high. Tokyo Electron still controls the global profit pool in coat/develop, and SCREEN and ACMR remain important cleaning references. Kingsemi does not need to defeat them globally, but it does need to keep domestic customers validating and expanding local content without triggering a ruinous price response. The indicator is advanced-node validation progress and repeat deployment with major fabs. The transmission path is slower order conversion, longer sales cycles, and renewed doubt about how much of the TAM is truly contestable.

11. Catalysts and tracking indicators

9.1 Positive catalysts

The best positive catalyst would be sustained proof that the second growth leg is real rather than aspirational. That means repeat orders in front-end chemical cleaning continuing beyond pilot lots, plus evidence that those orders are coming from major domestic customers rather than scattered smaller accounts. The annual-report summary already claims repeat orders from multiple large customers. A follow-through quarter that converts that into visible revenue would matter more than another general statement about strategic opportunity.

A second positive catalyst would be better quality growth in front-end track itself. The company says it has already achieved mass-production work with mainstream lithography tools in complex processes and is developing a new-generation track architecture matched to higher lithography throughput and tighter process precision. If that roadmap translates into successful customer validation and faster industrialization, the market will take it as evidence that the core franchise really can move higher up the process stack instead of remaining confined to narrower domestic layers.

A third positive catalyst would be operational evidence of NAURA synergies. This does not need to be a dramatic merger announcement. It could be simpler and more valuable: lower procurement cost, faster validation, broader customer access, or sustained margin improvement despite continued R&D intensity. The control change is already complete. The next stage of the story needs measurable benefits.

9.2 Negative catalysts

The most dangerous negative catalyst would be a quarter in which revenue still grows but gross margin slips back toward the mid-30s while cash burn remains severe. That combination would tell the market that 2026 Q1’s gross-margin recovery was a mix effect, not an economic turning point. Given the current valuation, that could compress the multiple quickly.

Another negative catalyst would be any explicit sign that price pressure is broadening rather than contained. The company already acknowledged market-opening price pressure on some products in 2025. If that wording reappears together with more asset-impairment charges, the market will be forced to ask whether the business is buying share at the expense of future returns.

A third negative catalyst would be a cooling of the domestic semicap trade itself. Kingsemi’s June 2026 rally happened in a broader environment of very strong investor appetite for semiconductor-equipment names. If that thematic premium fades, the highest-multiple names usually fall first. Kingsemi has made itself one of them.

9.3 Tracking dashboard

The first five indicators are about whether the business is converting technological progress into healthier economics. Revenue growth alone is not enough. Gross margin is the clearest signal of whether localization is happening on decent terms. R&D intensity should stay high, but if it climbs without revenue acceleration, the spending may be outrunning commercial absorption. Rolling cash conversion matters because semicap working capital can hide weakness for a while and then release it all at once. Inventory discipline matters because 2025 already showed that price pressure can leak into impairment.

The last three indicators are about the stock rather than only the business. Current P/S above 20 times already signals a market paying up for future platform status rather than present economics. The China 10-year government yield is the right independent check on margin of safety; with the latest 10-year yield around 1.73% on June 30, 2026, investors should at least demand an equity setup whose base-case annualized return is materially higher. Finally, global semiconductor-equipment billings help separate company-specific weakness from cycle noise. If industry billings stay firm and Kingsemi stalls, the problem is execution, not the cycle.

12. Cross-synthesis summary

Kingsemi has already proved one difficult thing. It has proved that a domestic Chinese equipment company can spend years climbing into one of the highest-sticky, highest-validation-burden steps in front-end manufacturing and come out with a commercially credible position rather than a laboratory story. That is the vertical conclusion that matters most. The company’s success did not come from luck, and it did not come only from policy. It came from choosing a process step where customer stickiness is unusually strong once validation succeeds, then surviving long enough to win that validation. That is a real capability. It is why NAURA wanted control and why the market keeps treating Kingsemi as strategically important even when trailing earnings look poor.

What the journey has not yet proved is that Kingsemi can convert strategic importance into stable, high-return economics. That is the horizontal conclusion. Against Tokyo Electron, Kingsemi is still the challenger in a category the incumbent overwhelmingly controls worldwide. Against SCREEN and ACMR, its cleaning business is promising but not yet comparably scaled. Against NAURA and AMEC, it remains much smaller in revenue, balance sheet, and R&D mass. The company’s real strength is not broad platform dominance. It is narrow strategic scarcity in front-end track, with a plausible path to wider wet-process relevance. The weakness is that strategic scarcity has already been priced as though the wider relevance were much more mature than it is.

That distinction answers the most important question in the stock today. The current valuation is not rewarding past success. It is pre-spending future success. A great many things have to happen for CNY 439.05 to look sensible even in hindsight: front-end track must keep moving up the localization curve, cleaning must become a repeat-order business line rather than just a validation success, NAURA must accelerate commercial execution rather than merely changing boxes on the ownership chart, and margin has to recover enough that owner earnings start to resemble the strategic value investors are paying for. The facts today support the possibility of that path. They do not support paying for it as though it were already largely achieved.

For the next year, the critical variables are gross margin, repeat-order evidence in cleaning, and cash conversion. For the next three years, the key variable is whether Kingsemi becomes a true two-leg story rather than a one-leg track specialist with distant adjacencies. For the next five years, the real question is whether NAURA’s ownership turns Kingsemi into a durable domestic process-franchise asset or merely places it inside a larger platform without changing its stand-alone economics enough. If the company can show that cleaning and packaging adjacencies reach scale while gross margin stabilizes and operating cash flow improves, the investment case changes materially. If margins remain pressured, cash stays unstable, and synergies remain rhetorical, then the strategic story can still be true while the stock remains a poor asset.

10.1 Bull and bear reasons

Bull reasons:

• Kingsemi remains one of the few domestic suppliers able to offer production-type front-end coat/develop tools in a category where localization is still low and validation stickiness is exceptionally strong.
• The front-end chemical cleaner has moved past launch into customer verification and repeat orders from multiple large domestic customers, opening a credible second growth leg.
• Q1 2026 revenue rose 20.08% and gross margin improved by 12.40 percentage points year on year, showing that the 2025 earnings hit was not simply a demand collapse.
• NAURA’s completed control acquisition gives Kingsemi board-level control, broader process complementarity, and potential leverage in R&D, supply chain, and customer access.

Bear reasons:

• The 2025 profit decline reflected high R&D and headcount expansion, plus lower government subsidies and higher inventory impairment caused by market-opening price pressure.
• Cash conversion remains unreliable, with operating cash flow negative in 2023 and again in 2026 Q1 despite ongoing revenue growth.
• Tokyo Electron still says global coater/developer share exceeds 90%, so Kingsemi is competing against one of the strongest incumbents in all semiconductor equipment.
• The June 2026 price surge and current valuation imply a future far ahead of what present owner earnings can justify, leaving little tolerance for ordinary execution shortfalls.
• NAURA booked about CNY 2.12 billion of goodwill on the acquisition, which means synergy expectations are financially embedded before they are fully proved operationally.

10.2 Pre-mortem: where might I be wrong

A plausible three-year down-50% script begins with commercialization looking good on revenue and bad on economics. Through 2027, domestic fabs keep validating Kingsemi’s track and cleaner tools, but customers insist on aggressive localization pricing while throughput and field-service costs stay high. Gross margin slips back toward 34%–35%, operating cash flow stays volatile, and Kingsemi keeps booking inventory write-downs on older configurations. The stock then de-rates from a narrative multiple closer to 45 times sales to something nearer the domestic large-cap semicap range. Even if revenue doubles, the share price could still halve from today because the multiple does most of the damage.

A second script is integration disappointment. NAURA’s ownership does not hurt operations, but the practical benefits come slower than the market assumes. By 2028, Kingsemi still has good products, yet cross-selling is limited, the cleaning business remains smaller than expected, and management turnover under the new structure slows roadmap execution. The market stops seeing a rising platform asset and starts seeing a narrow, capital-hungry specialist with a strategic parent. In that case, the stock does not need an earnings collapse to fall hard; it only needs the platform premium to shrink.

10.3 Final research conclusion

Kingsemi is a strategically serious company and, at the current quote, a poorly priced stock. The company has already done something difficult by building a real domestic position in front-end coat/develop and by turning cleaning from an R&D project into an early commercial reality. The NAURA control change strengthens the industrial logic. But the current market price asks investors to pay as though the second and third chapters of the story are much further along than the evidence shows. What worries me most is not a collapse in demand. It is the possibility that Kingsemi continues to grow, continues to matter strategically, and still produces disappointing shareholder returns because margin, cash conversion, and valuation all normalize from unsustainably optimistic levels.

What would change my mind is not another burst of price momentum. It would be operating proof. I would want to see cleaner repeat orders translating into a material revenue line, front-end track maintaining advanced-process progress without further price-led impairment, and a rolling cash-conversion profile that looks more like a maturing equipment franchise than a company constantly pulling future demand into current working capital. If those conditions arrive at a much lower entry price, this becomes more interesting very quickly. At CNY 439.05, the risk-reward is upside-starved even under a generous operating future.

【Company-profile scores】

• Fundamental quality: medium
• Growth: high
• Moat: medium
• Financial soundness: medium
• Management credibility: medium
• Valuation attractiveness: low
• Risk level: high
• Suitable investor type: event-driven

【Investment rating】

• Rating: Avoid
• One-line thesis: Strategic domestic track asset, but today’s valuation already assumes a far more mature platform than the operating evidence supports.
• 【Ideal Buy Price】90–110 CNY Basis: at least a 20% margin of safety below the conservative fair-value estimate of about CNY 115 per share derived from discounted 2028 sales and owner-earnings discipline.
• Acceptable hold price: 165–225 CNY
• Clearly overvalued price: 350 CNY and above
• Current-price classification: outside the three bands
• Whether to wait for a better price: yes. A patient entry only becomes attractive below roughly CNY 110, and preferably after two conditions appear together: repeated cleaner-order conversion into revenue and rolling four-quarter cash conversion above 0.8 times. The opportunity cost of waiting is missing further momentum, but the current downside from multiple compression is much larger.
• Target holding horizon: 3–5 years
• Expected annualized return: conservative about -36%; base about -24%; optimistic about -10% to -11%, all measured against the current price over a three-year horizon using the scenario values above.
• Max-loss risk: 50%+ is plausible if price pressure, cash-flow strain, and delayed synergy cause the valuation to compress toward larger domestic semicap peer ranges before earnings catch up.
• Reassessment-trigger signals:
  • if gross margin stays below 35% for two consecutive quarters
  • if operating cash flow remains negative over the next four reported quarters in aggregate
  • if cleaner repeat-order language stops appearing while R&D intensity remains elevated
  • if further inventory write-downs tied to selling-price pressure recur
  • if NAURA-related integration changes lead to visible technical-staff churn or heavy related-party dependence

【Valuation Range】

• current: 439.05 (close as of 2026-06-30)
• bear (conservative · ideal buy zone): [90, 110]
• base (fair · acceptable hold zone): [165, 225]
• bull (optimistic · above the clearly-overvalued line): [350, 390]

13. Key data tables

Historical financial snapshot

Source data come from Kingsemi’s 2025 annual-report summary, 2024 annual report, 2023 annual report, and 2026 Q1 report.

The business reason behind the table is simple. Revenue kept rising, but earnings and cash conversion stopped moving in sync. That pattern is consistent with a company widening its product map and customer base faster than its margin structure and working capital can mature. It supports the view that Kingsemi is still in an investment-heavy transition phase, but it also warns that the transition is not costless.

Peer valuation snapshot

Market-cap and multiple sources are current-quote pages and company disclosures available as of late June or early July 2026.

The table is not saying Kingsemi “should” trade at SCREEN’s or ACMR’s multiple. It is saying that Kingsemi’s current price asks investors to grant it a scarcity premium even above more diversified and more proven equipment companies. That is why the stock is vulnerable even if the operating story remains intact.

NAURA transaction summary

Source documents are the March 2025 acquisition announcement, the March 2025 public-bid announcement, Kingsemi’s June 2025 control-change announcement, and NAURA’s 2025 annual report.

The business reason behind these numbers is that control did not come cheaply or passively. NAURA paid cash, structured a two-step transaction, took board control, and recognized large goodwill. That is what real industrial intent looks like, but it also means the burden of proof on synergy is high.

14. Research uncertainties

The largest blind spot is line-item detail from the full 2025 annual report. I could verify the major drivers of earnings pressure through the annual-report summary, mirrored full-report text, and investor-relations materials, but I could not verify from primary accessible extracts that foreign-exchange loss was a principal driver on the same footing as labor-cost growth, lower subsidies, and inventory impairment.

The second uncertainty is customer granularity. Kingsemi explicitly withholds some information as commercial secret. That is understandable in semiconductor equipment, but it limits outside visibility on customer mix, validation depth, and exact order concentration by technology node.

The third uncertainty is maintenance versus growth capex. Public extracts do not provide a clean split, so the owner-earnings analysis necessarily uses a conservative approximation rather than a fully disclosed maintenance-capex figure.

The fourth uncertainty is synergy timing under NAURA. Control is completed and goodwill is booked, but the exact commercial and cost synergies are still mostly described in principle rather than demonstrated through several post-integration reporting periods.

15. Sources

Primary and near-primary sources for this report were Kingsemi’s 2025 annual-report summary, 2026 Q1 report, 2024 annual report, 2023 annual report, STAR-board company page, IPO prospectus, and June 2025 control-change filings.

For the NAURA transaction and governance change, I relied on NAURA’s March 2025 share-purchase announcement, March 2025 public-bid announcement, Kingsemi’s June 2025 control-change filing, and NAURA’s 2025 annual report.

For peer and industry benchmarking, I used Tokyo Electron investor-relations materials, TEL’s April 2026 transcript, SCREEN investor-relations pages, ACM Research’s SEC filings and results release, AMEC’s 2025 annual report, SEMI data, and public quote pages for current market multiples where appropriate.

For current market data and macro cross-checks, I used quoted June 30, 2026 closing-price pages for Kingsemi and peers, Kingsemi’s own June 30 risk reminder, China 10-year yield references, and USD/CNY historical-rate pages dated June 30, 2026.

Other tickers mentioned

• 002371.SHE: NAURA, Kingsemi’s new controlling shareholder and the domestic platform benchmark for strategy, governance, and valuation
• 688012.SHG: AMEC, domestic semicap leader used to benchmark R&D scale, margin structure, and premium platform valuation
• 8035.TSE: Tokyo Electron, the global coater/developer incumbent and Kingsemi’s most important product-level reference point
• 7735.TSE: SCREEN Holdings, a major wet-process and cleaning reference for Kingsemi’s second growth leg
• ACMR.US: ACM Research, the most relevant listed single-wafer-cleaning comparator for Kingsemi’s emerging cleaning business

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.